arrow
F

Frauke Goeman

irccs-regina elena national cancer institute
H指数:24
被引数:1,675

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma” [Exp Mol Pathol Volume 146, June 2026, 105049]

勘误:WNT/β-连环蛋白相关转录程序可预测肝癌患者的生存结局 [Exp Mol Pathol Volume 146, June 2026, 105049]

2026-05-280
OAAI
A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma

WNT/β-连环蛋白相关转录程序可预测肝细胞癌患者的生存结局

2026-05-110
OAAI
Dissecting endometrial cancer complexity in response to standard and targeted therapies

解析子宫内膜癌对标准疗法和靶向疗法的反应复杂性

2025-11-280
OAAI
A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis

一种预测性血清miRNA特征通过抑制调控铁死亡的关键因子EGLN1和TXNRD1来影响弥漫性大B细胞淋巴瘤细胞的存活能力。

2025-07-200
OA
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities (vol 3, 17022, 2017)

二甲双胍诱导的微rna 21-5p的消融释放Sestrin-1和CAB39L抗肿瘤活性 (第3卷,17022,2017)

2024-03-130
OAAI
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer
2024-03-017
OAAI
Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer (vol 41, 151, 2022)
2023-10-241
OAAI
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis

HSF-1/miR-145-5p转录轴增强腹腔热灌注化疗对腹膜卵巢癌的疗效

2023-08-193
OAAI
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
2023-07-174
OAAI
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas
2023-03-177
OAAI
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
2023-03-0112
OAAI
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
2022-07-2212
OAAI